Low hospital and long-term mortality in a prospective registry of facilitated percutaneous coronary intervention in acute myocardial infarction

American Journal of Cardiology

Volumn 92, Issue 1, 2003, Pages 67-71

  Rux, Sascha ^a   Lenßen, Kirstin ^a   Sonntag, Steffen ^a   Thieme, Torsten ^a   Bruch, Leonhard ^a   Waurick, Peer Ekkehart ^a   Kleber, Franz Xaver ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; EPTIFIBATIDE; HEPARIN; RETEPLASE; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0037524298     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00470-3     Document Type: Article

References (20)

1. Matsui K., Polanczyk C.A., Gaspoz J.M., Theres H., Kleber F.X., Sobashima A., Okamatsu S., Viana J.M., Ribeiro J.P., Emonet S., Lee T.H. Management of patients with acute myocardial infarction at five academic medical centers clinical characteristics, resource utilization, and outcome . J Investig Med. 47:1999;134-140.
2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
3. Lefkovits J., Ivanhoe R.J., Califf R.M., Bergelson B.A., Anderson K.M., Stoner G.L., Weisman H.F., Topol E.J. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-months outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 77:1996;1045-1051.
4. Yasuda T., Gold H.K., Leinbach R.C., Saito T., Guerrero L., Jang I.K., Holt R., Fallon J.T., Collen D. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody. J Am Coll Cardiol. 16:1990;1728-1735.
5. Ohman E.M., Kleiman N.S., Gacioch G., Worley S.J., Navetta F.I., Talley J.D., Anderson H.V., Ellis S.G., Cohen M.D., Spriggs D., et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin for acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation. 95:1997;846-854.
6. Antman E.M., Giugliano R.P., Gibson C.M., McGabe C.H., Coussement P., Kleimann N.S., Vahanian A., Adgey A.A.J., Menown I., Rupprecht H.J., et al. Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation. 99:1999;2720-2732.
7. Hermann H.C., Moliterno D.J., Ohman E.M., Stebbins A.L., Bode C., Betriu A., Forcycki F., Miklin J.S., Bachinsky W.B., Lincoff A.M., Califf R.M., Topol E.J. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction results from SPEED (GUSTO 4 Pilot) Trial . J Am Coll Cardiol. 36:2000;1489-1496.
8. Cannon C.P. Bridging the gap with new strategies in acute ST elevation myocardial infarction bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention and "facilitated" PCI . J Thromb Thrombolysis. 9:2000;235-241.
9. Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination of reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition the GUSTO V randomised trial . Lancet. 357:2001;1905-1914.
10. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin the ASSENT-3 randomised trial in acute myocardial infarction . Lancet. 358:2001;605-613.
11. Reimer K.A., Lowe J.E., Rassmussen M.M., Jennings R.B. The wave front phenomenon of ischemic cell death myocardial infarct size vs. duration of coronary occlusion in dogs . Circulation. 56:1977;786-794.
12. Stern R., Arntz H.R. Prehospital thrombolysis in acute myocardial infarction. Eur J Emerg Med. 5:1998;471-479.
13. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neil W.W., Morice M.C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 341:1999;1949-1956.
14. Le May M.R., Labinaz M., Davies R.F., Marquis J.F., Laramée L.A., O'Brien E.R., Williams W.L., Beanlands R.S., Nichol G., Higgison L.A. Stenting versus Thrombolysis in Acute myocardial infarction Trial (STAT). J Am Coll Cardiol. 37:2001;985-991.
15. Schömig A., Kastrati A., Dirschinger J., Mehilli J., Schricke U., Pache J., Martinoff S., Neumann F.J., Schwaiger M. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 343:2000;385-391.
16. Bonnefoy E., Lapostolle F., Leizorovicz A., Steg G., McFadden E.P., Dubien P.Y., Cattan S., Boullenger E., Machecourt J., Lacroute J.M., et al. Primary angioplasty versus prehospital thrombolysis in the acute myocardial infarction a randomized study . Lancet. 360:2002;825-829.
17. Kastrati A., Mehilli J., Dirchinger J., Schricke U., Neverve J., Pache J., Martinoff S., Neumann F.J., Nekolla S., Blasini R., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction a randomised trial . Lancet. 359:2002;920-925.
18. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., White H.D., Talley J.D., Buller C.E., Jacobs A.K., Slater J.N., Col J., et al. Early revascularisation in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 341:1999;625-634.
19. Ryan T.J., Antman E.M., Brooks N.H., Califf R.M., Hillis L.D., Hiratzka L.F., Rapaport E., Riegel B., Russel R.O., Smith E.E., et al. Update ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) . J Am Coll Cardiol. 34:1999;890-911.
20. Van de Werf F., Ardissino D., Betriu A., Cokkinos D.V., Falk E., Fox K.A.A., Julian D., Lengyel M., Neumann F.J., Ruzyllo W., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 24:2003;28-66.